Genetic glomerular disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:183586
Who is this for?
Show terms as
14Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic glomerular disease is a broad category (Orphanet group code 183586) encompassing a heterogeneous group of inherited kidney disorders that primarily affect the glomeruli — the tiny filtering units within the kidneys responsible for removing waste and excess fluid from the blood. These conditions result from pathogenic variants in genes encoding structural or regulatory proteins essential for normal glomerular function, including components of the glomerular basement membrane, podocyte cytoskeleton, slit diaphragm, and other filtration barrier elements. This grouping includes well-characterized entities such as Alport syndrome, congenital nephrotic syndrome (Finnish type), steroid-resistant nephrotic syndrome due to mutations in genes like NPHS1, NPHS2, WT1, LAMB2, and others, as well as familial forms of focal segmental glomerulosclerosis (FSGS). Clinical features vary by specific diagnosis but commonly include proteinuria (excess protein in the urine), hematuria (blood in the urine), edema (swelling), hypertension, and progressive decline in kidney function that may ultimately lead to end-stage kidney disease (ESKD) requiring dialysis or kidney transplantation. The age of onset, severity, and rate of progression differ substantially depending on the underlying genetic cause. Some forms present in the neonatal period with massive proteinuria, while others may not manifest until adulthood. Treatment is largely supportive and may include angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) to reduce proteinuria and slow disease progression, management of edema with diuretics, dietary modifications, and ultimately renal replacement therapy when kidney failure occurs. Immunosuppressive therapies, which are effective in many acquired glomerular diseases, are generally ineffective in genetically determined forms. Genetic testing plays an increasingly important role in diagnosis, guiding treatment decisions, and informing family counseling.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Genetic glomerular disease.

View clinical trials →

No actively recruiting trials found for Genetic glomerular disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Genetic glomerular disease community →

Specialists

14 foundView all specialists →
BP
Benjamin A Weinstock, PhD
LITTLE NECK, NY
Specialist
PI on 1 active trial
JM
Jeffrey Lebensburger, DO, MSPH
BIRMINGHAM, AL
Specialist
PI on 1 active trial
EM
eleonora riccio, md
Specialist
PI on 2 active trials
DP
Dominique JOLY, MD, PhD
Specialist
PI on 2 active trials
HM
Hann-Chorng Kuo, M.D.
Specialist
PI on 6 active trials
AM
Anirban Ganguli, M.D.
WASHINGTON, DC
Specialist
PI on 2 active trials
RP
Rian Dişçi, Professor
Specialist
PI on 1 active trial2 Genetic glomerular disease publications
FD
Frank Mose, MD, Ph D
Specialist
PI on 1 active trial
GM
Godela M Brosnahan, MD
Specialist
PI on 1 active trial1 Genetic glomerular disease publication
TM
Trine Z Lyksholm, MD
Specialist
PI on 2 active trials
EM
Eiji Higashihara, M.D.
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic glomerular disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic glomerular diseaseForum →

No community posts yet. Be the first to share your experience with Genetic glomerular disease.

Start the conversation →

Latest news about Genetic glomerular disease

No recent news articles for Genetic glomerular disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Genetic glomerular disease

What is Genetic glomerular disease?

Genetic glomerular disease is a broad category (Orphanet group code 183586) encompassing a heterogeneous group of inherited kidney disorders that primarily affect the glomeruli — the tiny filtering units within the kidneys responsible for removing waste and excess fluid from the blood. These conditions result from pathogenic variants in genes encoding structural or regulatory proteins essential for normal glomerular function, including components of the glomerular basement membrane, podocyte cytoskeleton, slit diaphragm, and other filtration barrier elements. This grouping includes well-chara

Which specialists treat Genetic glomerular disease?

14 specialists and care centers treating Genetic glomerular disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.